<SEC-DOCUMENT>0000899140-21-000094.txt : 20210127
<SEC-HEADER>0000899140-21-000094.hdr.sgml : 20210127
<ACCEPTANCE-DATETIME>20210127173000
ACCESSION NUMBER:		0000899140-21-000094
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210127
DATE AS OF CHANGE:		20210127
GROUP MEMBERS:		INNOVIVA STRATEGIC OPPORTUNITIES LLC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Armata Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0000921114
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				911549568
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-44887
		FILM NUMBER:		21561096

	BUSINESS ADDRESS:	
		STREET 1:		4503 GLENCOE AVENUE
		CITY:			MARINA DEL REY
		STATE:			CA
		ZIP:			90292
		BUSINESS PHONE:		310-665-2928

	MAIL ADDRESS:	
		STREET 1:		4503 GLENCOE AVENUE
		CITY:			MARINA DEL REY
		STATE:			CA
		ZIP:			90292

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AmpliPhi Biosciences Corp
		DATE OF NAME CHANGE:	20130222

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGETED GENETICS CORP /WA/
		DATE OF NAME CHANGE:	19940331

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Innoviva, Inc.
		CENTRAL INDEX KEY:			0001080014
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943265960
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		6502389600

	MAIL ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	THERAVANCE INC
		DATE OF NAME CHANGE:	20020207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED MEDICINE INC
		DATE OF NAME CHANGE:	20000302
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>i40476268a.htm
<DESCRIPTION>SCHEDULE 13D/A, AMENDMENT #2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: asdf
         Document created using EDGARfilings PROfile 7.2.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div><br>
  </div>
  <div><br>
  </div>
  <div>
    <div>
      <div><br>
      </div>
      <div style="text-align: center; margin-right: 166.6pt; margin-left: 166.9pt; margin-top: 4.45pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; margin-right: 166.6pt; margin-left: 167pt; margin-top: 0.5pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; margin-right: 166.45pt; margin-left: 167pt; margin-top: 2.05pt; font-weight: bold;">Washington, D.C.&#160; 20549</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="margin-top: 0.5pt;"><br>
      </div>
      <div style="text-align: center; margin-right: 166.6pt; margin-left: 166.95pt; font-size: 14pt; font-weight: bold;">SCHEDULE 13D/A</div>
      <div style="text-align: center; margin-right: 178.95pt; margin-left: 179.45pt; margin-top: 1.35pt; font-weight: bold;">Under the Securities Exchange Act of 1934 (Amendment No. 2)*</div>
      <div><br>
      </div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">ARMATA PHARMACEUTICALS, INC.</div>
      <div style="margin-top: 0.1pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; margin-right: 166.6pt; margin-left: 166.9pt; margin-top: 1.15pt;">(Name of Issuer)</div>
      <div style="margin-top: 1.15pt;"><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Common Stock, $0.01 par value</div>
      <div style="margin-top: 0.1pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; margin-right: 166.55pt; margin-left: 167pt; margin-top: 1.15pt;">(Title of Class of Securities)</div>
      <div style="margin-top: 1.15pt;"><br>
      </div>
      <div style="text-align: center; font-weight: bold;">04216R 102</div>
      <div style="margin-top: 0.1pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; margin-right: 166.6pt; margin-left: 166.9pt; margin-top: 1.15pt;">(CUSIP Number)</div>
      <div style="margin-top: 1.15pt;"><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Pavel Raifeld<br>
      </div>
      <div style="text-align: center; font-weight: bold;">Chief Executive Officer</div>
      <div style="text-align: center; font-weight: bold;">Innoviva, Inc.</div>
      <div style="text-align: center; font-weight: bold;">1350 Old Bayshore Highway Suite 400</div>
      <div style="text-align: center; font-weight: bold;">Burlingame, CA</div>
      <div style="text-align: center; font-weight: bold;">877-202-1097</div>
      <div style="margin-top: 0.1pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="margin: 1.15pt 0px 0px; font-family: 'Times New Roman',Times,serif; text-align: center;">(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</div>
      <div style="margin-top: 1.15pt;"><br>
      </div>
      <div style="text-align: center; font-weight: bold;">January 26, 2021</div>
      <div style="margin-top: 0.25pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="margin: 1.15pt 0px 0px; font-family: 'Times New Roman',Times,serif; text-align: center;">(Date of Event which Requires Filing of this Statement)</div>
      <div style="margin-top: 0.45pt;"><br>
      </div>
      <div style="text-align: justify; margin-right: 60.15pt; margin-left: 59pt;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because
        of &#167;&#167;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.&#160; &#9744;</div>
      <div style="margin-top: 0.45pt;"><br>
      </div>
      <div style="text-align: justify; margin-right: 60.2pt; margin-left: 59pt; margin-top: 4.55pt;"><font style="font-weight: bold;">Note</font>: Schedules filed in paper format shall include a signed original and five copies of the schedule, including
        all exhibits. See &#167;240.13d-7 for other parties to whom copies are to be sent.</div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-right: 60.05pt; margin-left: 58.95pt; margin-top: 0.05pt;"><font style="font-size: 8pt;">* </font>The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with
        respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.</div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-right: 60.15pt; margin-left: 58.95pt; margin-top: 0.05pt;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange
        Act of 1934 (&#8220;Act&#8221;) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
      <div style="margin-top: 0.45pt;"><br>
      </div>
      <div style="margin-right: 117.45pt; margin-left: 86pt; margin-top: 5.75pt; font-weight: bold;">Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB
        control number.</div>
      <div style="margin-top: 0.1pt;"><br>
      </div>
      <div style="clear: both; margin-top: 12pt; margin-bottom: 12pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">1</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>CUSIP No.&#160; 04216R 102<br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 12pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">1</font>&#160;</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">Names of Reporting Persons.<br>
                </div>
                <div style="font-size: 10pt;">I.R.S. Identification Nos. of above persons (entities only).<br>
                </div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;">
                  <div><font style="font-size: 10pt;"><u>Innoviva, Inc.</u></font> <br>
                  </div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">2</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
                <div style="font-size: 10pt;">(a)&#160; &#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (b)&#160;&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
                <div>&#160; <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">3</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">SEC USE ONLY</div>
                <div>&#160; <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">4</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">SOURCE OF FUNDS</div>
                <div>&#160;</div>
                <div><font style="font-size: 10pt;">WC</font> <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">5</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
                <div>&#160;</div>
                <div>&#9744; <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">6</font></div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
                <div>&#160;</div>
                <div>Delaware <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 17.03%; vertical-align: middle; border-left: #000000 2px solid;" rowspan="4" colspan="3">
                <div style="text-align: center; font-size: 10pt;">NUMBER&#160;OF</div>
                <div style="text-align: center; font-size: 10pt;">SHARES</div>
                <div style="text-align: center; font-size: 10pt;">BENEFICIALLY</div>
                <div style="text-align: center; font-size: 10pt;">OWNED&#160;BY</div>
                <div style="text-align: center; font-size: 10pt;">EACH</div>
                <div style="text-align: center; font-size: 10pt;">REPORTING</div>
                <div style="text-align: center; font-size: 10pt;">PERSON</div>
                <div style="text-align: center; font-size: 10pt;">WITH</div>
                <div style="margin-bottom: 1pt; font-size: 10pt;">&#160;</div>
                <div>&#160;</div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 2.76%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">7</font>&#160;</div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 77.48%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">SOLE VOTING POWER</div>
                <div>&#160;</div>
                <div><font style="font-size: 10pt;">17,421,600</font> <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 7.74%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">8</font></div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">SHARED VOTING POWER</div>
                <div>&#160;</div>
                <div><font style="font-size: 10pt;">3,735,824</font> <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 7.74%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">9</font></div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt;">SOLE DISPOSITIVE POWER</div>
                <div>&#160;</div>
                <div><font style="font-size: 10pt;">17,421,600 </font><br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 7.74%; vertical-align: top;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">10</div>
              </td>
              <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid;">
                <div>&#160;&#160;</div>
              </td>
              <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid;">
                <div style="font-size: 10pt;">SHARED DISPOSITIVE POWER</div>
                <div>&#160;</div>
                <font style="font-size: 10pt;">3,735,824</font> </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">11</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;"><font style="font-size: 10pt;">21,157,424</font> <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">12</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">13</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt;"><font style="font-size: 10pt;">68%</font> <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="font-size: 10pt; font-weight: bold; text-align: center;">14</div>
              </td>
              <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                <div style="font-size: 10pt;">TYPE OF REPORTING PERSON</div>
                <div>&#160;</div>
                <div style="margin-bottom: 1pt; font-size: 10pt;">CO</div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div> </div>
      <div>&#160;
        <table cellspacing="0" cellpadding="0" id="zb40f93aab98948d1806aa0c5e77f41cf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 0.5pt;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">(1)</td>
              <td style="width: auto; vertical-align: top;">
                <div>See Item 5.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z83a0e587190242cd8d887952c8669cd9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 0.5pt;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">(2)</td>
              <td style="width: auto; vertical-align: top;">
                <div>Based on 31,135,085 shares of common stock, par value $0.01 per share (&#8220;Common Stock&#8221;), outstanding as of January 26, 2021, as confirmed in writing by the Issuer, inclusive of the shares of Common Stock beneficially owned by the
                  Reporting Persons and shares of Common Stock issuable upon exercise of the warrants to purchase Common Stock beneficially owned by the Reporting Persons.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="margin-top: 0.5pt;"><br>
      </div>
      <div style="clear: both; margin-top: 12pt; margin-bottom: 12pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div>CUSIP No.&#160; 04216R 102<br>
        </div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
        <div><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 12pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">1</font>&#160;</div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">Names of Reporting Persons.<br>
                  </div>
                  <div style="font-size: 10pt;">I.R.S. Identification Nos. of above persons (entities only).<br>
                  </div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt;">
                    <div><font style="font-size: 10pt;"><u>Innoviva Strategic Opportunities LLC</u></font> <br>
                    </div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">2</font></div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
                  <div style="font-size: 10pt;">(a)&#160; &#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (b)&#160;&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
                  <div style="margin-bottom: 1pt;">&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">3</font></div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">SEC USE ONLY</div>
                  <div style="margin-bottom: 1pt;">&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">4</font></div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">SOURCE OF FUNDS</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt; font-size: 10pt;">WC</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">5</font></div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">6</font></div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt; font-size: 10pt;">Delaware</div>
                </td>
              </tr>
              <tr>
                <td style="width: 17.03%; vertical-align: middle; border-left: #000000 2px solid;" rowspan="4" colspan="3">
                  <div style="text-align: center; font-size: 10pt;">NUMBER&#160;OF</div>
                  <div style="text-align: center; font-size: 10pt;">SHARES</div>
                  <div style="text-align: center; font-size: 10pt;">BENEFICIALLY</div>
                  <div style="text-align: center; font-size: 10pt;">OWNED&#160;BY</div>
                  <div style="text-align: center; font-size: 10pt;">EACH</div>
                  <div style="text-align: center; font-size: 10pt;">REPORTING</div>
                  <div style="text-align: center; font-size: 10pt;">PERSON</div>
                  <div style="margin-bottom: 1pt; font-size: 10pt; text-align: center;">WITH <br>
                  </div>
                  <div>&#160;</div>
                </td>
                <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;&#160;</div>
                </td>
                <td style="width: 2.76%; vertical-align: top; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">7</font>&#160;</div>
                </td>
                <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;&#160;</div>
                </td>
                <td style="width: 77.48%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt;">SOLE VOTING POWER</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt; font-size: 10pt;">0</div>
                </td>
              </tr>
              <tr>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;&#160;</div>
                </td>
                <td style="width: 7.74%; vertical-align: top; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">8</font></div>
                </td>
                <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;&#160;</div>
                </td>
                <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt;">SHARED VOTING POWER</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt;"><font style="font-size: 10pt;">3,735,824</font><br>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;&#160;</div>
                </td>
                <td style="width: 7.74%; vertical-align: top; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; text-align: center;">&#160;&#160;<font style="font-weight: bold;">9</font></div>
                </td>
                <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;&#160;</div>
                </td>
                <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt;">SOLE DISPOSITIVE POWER</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt; font-size: 10pt;">0</div>
                </td>
              </tr>
              <tr>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid;">
                  <div>&#160;&#160;</div>
                </td>
                <td style="width: 7.74%; vertical-align: top;">
                  <div style="font-size: 10pt; font-weight: bold; text-align: center;">10</div>
                </td>
                <td style="width: 1.37%; vertical-align: bottom; border-left: #000000 2px solid;">
                  <div>&#160;&#160;</div>
                </td>
                <td style="width: 2.76%; vertical-align: top; border-right: #000000 2px solid;">
                  <div style="font-size: 10pt;">SHARED DISPOSITIVE POWER</div>
                  <div>&#160;</div>
                  <font style="font-size: 10pt;">3,735,824 </font> </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; font-weight: bold; text-align: center;">11</div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt;"><font style="font-size: 10pt;">3,735,824</font> <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; font-weight: bold; text-align: center;">12</div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; font-weight: bold; text-align: center;">13</div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt;"><font style="font-size: 10pt;">12.7%</font> <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><br>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.75%; vertical-align: top; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div style="font-size: 10pt; font-weight: bold; text-align: center;">14</div>
                </td>
                <td style="width: 1.55%; vertical-align: bottom; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                </td>
                <td style="width: 90.71%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;" colspan="5">
                  <div style="font-size: 10pt;">TYPE OF REPORTING PERSON</div>
                  <div>&#160;</div>
                  <div style="margin-bottom: 1pt; font-size: 10pt;">OO</div>
                </td>
              </tr>

          </table>
        </div>
        <br>
        <div> </div>
        <div>&#160;
          <table cellspacing="0" cellpadding="0" id="z6abbbf952bc64b4981483321cf2dc985" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 0.5pt;">

              <tr>
                <td style="width: 18pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">(1)</td>
                <td style="width: auto; vertical-align: top;">
                  <div>See Item 5.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z2ab6825e7245459d85cda25ac9530c53" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 0.5pt;">

              <tr>
                <td style="width: 18pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top; align: right;">(2)</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Based on 31,135,085 shares of common stock, par value $0.01 per share (&#8220;Common Stock&#8221;), outstanding as of January 26, 2021, as confirmed in writing by the Issuer, inclusive of the shares of Common Stock directly held by Innoviva
                    Strategic Opportunities LLC (&#8220;Innoviva Sub&#8221;) and shares of Common Stock issuable upon exercise of the warrants to purchase Common Stock beneficially owned by the Reporting Persons.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="margin-top: 0.5pt;"><br>
        </div>
      </div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div style="margin-top: 0.2pt;"><br>
        </div>
        <div style="text-align: center; margin-left: 22.4pt; font-weight: bold;">Explanatory Note</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">This Amendment No. 2 to Schedule 13D (&#8220;Amendment No. 2&#8221;) amends and supplements the initial Statement of Beneficial Ownership on
          Schedule 13D, as filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) by Innoviva, Inc. (&#8220;Innoviva&#8221;) on February 14, 2020, as amended and supplemented by Amendment No. 1 filed with the SEC on March 31, 2020 by Innoviva (the
          &#8220;Schedule 13D&#8221;), with respect to shares of common stock, $0.01 par value per share (&#8220;Common Stock&#8221;) of Armata Pharmaceuticals, Inc., a Washington corporation (the &#8220;Issuer&#8221;) and warrants to acquire additional shares of Common Stock of the Issuer
          (&#8220;Warrants&#8221;).</div>
        <div style="margin-top: 0.05pt;"><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Innoviva and Innoviva Strategic Opportunities LLC, a wholly-owned subsidiary of Innoviva (&#8220;Innoviva Sub&#8221; and, together with
          Innoviva, the &#8220;Reporting Persons&#8221;) are filing this amendment to reflect the acquisition of additional shares of Common Stock and Warrants.&#160; Except as specifically amended and supplemented by this Amendment No. 2, the Schedule 13D (as amended)
          remains in full force and effect.</div>
        <div style="margin-top: 0.45pt;"><br>
        </div>
        <div style="margin-left: 22.4pt; font-weight: bold;">Item 2. Identity and Background</div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Item 2 in Schedule 13D is hereby supplemented as follows:</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Innoviva Strategic Opportunities LLC (&#8220;Innoviva Sub&#8221;) is a wholly-owned subsidiary of Innoviva which was formed on November 25,
          2020.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">The address of the principal business office of Innoviva Sub is: c/o Innoviva, Inc., 1350 Old Bayshore Highway Suite 400&#160;
          Burlingame, CA.</div>
        <div style="margin-left: 36pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Neither Reporting Person has been, (a) with respect to Innoviva, in the last five years, and (b) with respect to Innoviva Sub,
          since the date of its formation: (i) convicted in a criminal proceeding, or (ii) a party to any other civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which the Reporting Person is or has been
          subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</div>
        <div style="margin-top: 0.25pt;"><br>
        </div>
        <div style="margin-left: 23.6pt; margin-top: 0.05pt; font-weight: bold;">Item 3. Source and Amount of Funds or Other Consideration</div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Item 3 of Schedule 13D is hereby supplemented as follows:</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Innoviva Sub acquired the Newly Purchased Common Stock and the Newly Purchased Warrants (each as defined below) for an aggregate
          purchase price of approximately $6.1 million.&#160; The Newly Purchased Common Stock and the Newly Purchased Warrants were acquired with funds provided from working capital of the Reporting Persons.</div>
        <div style="margin-top: 0.15pt;"><br>
        </div>
        <div style="margin-left: 23.55pt; margin-top: 0.05pt; font-weight: bold;">Item 4. Purpose of Transaction</div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Item 4 of Schedule 13D is supplemented as follows:</div>
        <div style="margin-top: 0.05pt;"><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">On January 26, 2021, Innoviva Sub entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with the Issuer and acquired 1,867,912
          newly issued Common Stock (&#8220;Newly Purchased Common Stock&#8221;) and Warrants to acquire 1,867,912 shares of Common Stock, with an exercise price per share of $3.25 (&#8220;Newly Purchased Warrants&#8221;).&#160; Pursuant to the terms of the SPA, Innoviva sub may
          acquire an additional 4,285,935 shares of Common Stock and additional Warrants to purchase 4,285,935 shares of Common Stock of the Issuer, subject to satisfaction of certain conditions set forth in the SPA, including approval by the stockholders
          of the Issuer as may be required by the applicable rules and regulations of New York Stock Exchange American.&#160; Innoviva Sub entered into the transaction for investment purposes.&#160; On the date of this Amendment No. 2, the Reporting Persons
          collectively own 10,578,712 shares of Common Stock of the Issuer and warrants to acquire an additional 10,578,712 shares of Common Stock of the Issuer.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">The SPA is attached as Exhibits 10.1 and the form of Warrant is attached as Exhibit 4.1 to the Form 8-K of the Issuer filed with
          the SEC on January 27, 2021 and each is incorporated herein by reference; any description herein is qualified in its entirety by reference to the document so filed by the Issuer.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">The Reporting Persons may, from time to time and at any time, either alone or together with others: (i)&#160;acquire additional Common
          Stock and Warrants and/or other equity, debt, notes, instruments or other securities (collectively, &#8220;Securities&#8221;) of the Issuer in the open market or otherwise; (ii)&#160;dispose of any or all of its Securities in the open market or otherwise; or
          (iii)&#160;engage in any hedging or similar transactions with respect to the Securities.</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-top: 0.35pt;"><br>
        </div>
        <div style="margin-left: 23pt; font-weight: bold;">Item 5. Interest in Securities of the Issuer</div>
        <div style="margin-top: 0.15pt;"><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Item 5 of Schedule 13D is amended and restated as follows:</div>
        <div style="margin-top: 0.05pt;"><br>
        </div>
        <div style="margin-left: 18pt; margin-top: 0.5pt;">The Reporting Persons collectively may be deemed to have beneficial ownership of 21,157,424 shares of Common Stock, representing approximately 68% of the outstanding shares of Common Stock of the
          Issuer as of the date of this Amendment No.2,&#160; based on 31,135,085 shares of Common Stock outstanding as of January 26, 2021, as confirmed in writing by the Issuer, inclusive of the shares of Common Stock beneficially owned by the Reporting
          Persons and shares of Common Stock issuable upon exercise of the warrants to purchase Common Stock beneficially owned by the Reporting Persons.</div>
        <div style="margin-top: 0.05pt;"><br>
        </div>
        <div style="margin-top: 0.05pt;"><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">Except as set forth in Item 4, the Reporting Persons did not acquire or sell any shares of Common Stock or other securities of the
          Issuer during the last 60 days.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">As part of the transactions contemplated by the SPA, the Reporting Persons entered into a voting agreement (the &#8220;Voting Agreement&#8221;)
          with the Issuer, pursuant to which the Reporting Persons agreed not to vote or take any action by written consent with respect to shares of Common Stock of the Issuer held by the Reporting Persons or any of their subsidiaries which represent, in
          the aggregate, more than 49.5% of the total number of issued and outstanding shares of Common Stock of the Issuer as of any given record date for voting (such shares, the &#8220;Excess Shares&#8221;) on the matters related to the election or removal of
          directors from the board of directors (the &#8220;Board&#8221;) of the Issuer (&#8220;Board Matters&#8221;) presented at any meeting of the stockholders of the Issuer (or any adjournment or postponement thereof) or for their action by written consent, in each case,
          unless the Board authorizes the Reporting Persons to vote such Excess Shares with respect to Board Matters.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 23.65pt; margin-left: 22.4pt; margin-top: 0.05pt;">The Voting Agreement is attached as Exhibit 10.4 to the Form 8-K of the Issuer filed with the SEC on January 27, 2021 and is
          incorporated herein by reference; any description herein of the Voting Agreement is qualified in its entirety by reference to the Voting Agreement so filed by the Issuer.</div>
        <div style="margin-top: 0.5pt;"><br>
        </div>
        <div style="margin-left: 23pt; margin-top: 0.05pt; font-weight: bold;">Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer</div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="text-align: justify; margin-left: 36pt;">Item 6 of Schedule 13 D is supplemented as follows:</div>
        <div><br>
        </div>
        <div style="text-align: justify; margin-left: 36pt;">The information contained in Item 5 of Amendment No. 2 is hereby incorporated by reference into this Item 6.</div>
        <div><br>
        </div>
        <div style="text-align: justify; margin-left: 36pt;">The Reporting Persons entered into an Amended and Restated Investor Rights Agreement, dated as of January 26, 2021, by and between the Reporting Persons and the Issuer (the &#8220;Investor Rights
          Agreement&#8221;), pursuant to which the Reporting Persons have been granted certain rights, including participation rights with respect to issuances of new securities by the Issuer, certain information rights and, subject to minimum ownership
          thresholds, the right to designate two directors to the Board.</div>
        <div><br>
        </div>
        <div style="text-align: justify; margin-left: 36pt;">The Investor Rights Agreement is attached as Exhibit 10.2 to the Form 8-K of the Issuer filed with the SEC on January 27, 2021 and is incorporated herein by reference; any description herein of
          the Investor Rights Agreement is qualified in its entirety by reference to the Investor Rights Agreement so filed by the Issuer.</div>
        <div><br>
        </div>
        <div style="text-align: justify; margin-left: 36pt;">Innoviva Sub also entered into a Registration Rights Agreement, dated as of January 26, 2021, with the Issuer (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Issuer is required to
          file a registration statement on Form S-1 or Form S-3 (the &#8220;Shelf Registration Statement&#8221;) covering the resale of the securities issued and sold pursuant to the SPA with the SEC on a continuous basis pursuant to Rule 415 promulgated under the
          Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or if Rule 415 is not available for offers and sales of such securities, by such other means of distribution of such securities as the Reporting Persons may reasonably specify. The Issuer
          must use its commercially reasonable efforts to cause the Shelf Registration Statement to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event (i) no later than the fifteenth day
          following the filing of the Shelf Registration Statement in the event of no &#8220;review&#8221; by the Commission, (ii) no later than the sixtieth day following the filing of the Shelf Registration Statement in the event of &#8220;limited review&#8221; by the
          Commission, or (iii) in the event of a &#8220;review&#8221; by the Commission, the one hundred and twentieth day following the filing of the Shelf Registration Statement, subject to certain exceptions.</div>
        <div><br>
        </div>
        <div style="text-align: justify; margin-left: 36pt;">The Registration Rights Agreement is attached as Exhibit 10.3 to the Form 8-K of the Issuer filed with the SEC on January 27, 2021 and is incorporated herein by reference; any description herein
          of the Registration Rights Agreement is qualified in its entirety by reference to the Registration Rights Agreement so filed by the Issuer.</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-left: 23pt; margin-top: 3.15pt; font-weight: bold;">Item 7. Material to Be Filed as Exhibits</div>
        <div style="margin-top: 0.45pt;"><br>
        </div>
        <div style="margin-left: 36pt;">Exhibit 1 &#8211; Securities Purchase Agreement, dated as of January 26, 2021, by and between Armata Pharmaceuticals, Inc. and Innoviva Strategic Opportunities LLC (incorporated by reference to Exhibit 10.1 to the Form 8-K
          of the Issuer filed with the U.S. Securities and Exchange Commission on January 27, 2021)</div>
        <div style="margin-left: 36pt;">Exhibit 2 &#8211; Voting Agreement, by and among Innoviva, Inc., Innoviva Strategic Opportunities LLC, and Armata Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.4 to the Form 8-K of the Issuer filed with
          the U.S. Securities and Exchange Commission on January 27, 2021)</div>
        <div style="margin-left: 36pt;">Exhibit 3 &#8211; Amended and Restated Investor Rights Agreement, dated as of January 26, 2021, by and among Armata Pharmaceuticals, Inc., Innoviva, Inc. and Innoviva Strategic Opportunities LLC (incorporated by reference
          to Exhibit 10.2 to the Form 8-K of the Issuer filed with the U.S. Securities and Exchange Commission on January 27, 2021)</div>
        <div style="margin-left: 36pt;">Exhibit 4 &#8211; Registration Rights Agreement, dated as of January 26, 2021, by and between Armata Pharmaceuticals, Inc. and Innoviva Strategic Opportunities LLC (incorporated by reference to Exhibit 10.3 to the Form 8-K
          of the Issuer filed with the U.S. Securities and Exchange Commission on January 27, 2021)</div>
        <div style="margin-left: 36pt;">Exhibit 5 &#8211; Form of Warrant (incorporated by reference to Exhibit 4.1 to the Form 8-K of the Issuer filed with the U.S. Securities and Exchange Commission on January 27, 2021)</div>
        <div style="margin-left: 36pt;">Exhibit 99.1 &#8211; Joint Filing Agreement, as required by Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended</div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div style="margin-left: 36pt;"> <br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
      </div>
      <br>
      <div style="text-align: center; margin-left: 23pt; font-weight: bold;">SIGNATURE</div>
      <div style="margin-top: 0.45pt;"><br>
      </div>
      <div style="margin: 0px; text-align: justify; text-indent: 0px;">
        <div style="text-indent: 36pt; margin-right: 23.6pt;">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.</div>
        <div><br>
        </div>
        <div style="margin-right: 23.6pt; margin-left: 36pt;">Dated: January 27, 2021</div>
        <div><br>
        </div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" id="z51e8ebd975f74ce9842393543f6ba92a" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="vertical-align: top;" colspan="2">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">INNOVIVA, INC.</div>
              </td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">By:</div>
              </td>
              <td style="width: 27.67%; vertical-align: top;">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;"><u>/s/ Pavel Raifeld&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
                  </u></div>
              </td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">Name: Pavel Raifeld</div>
              </td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">Title: Chief Executive Officer</div>
              </td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="vertical-align: top;" colspan="2">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">INNOVIVA STRATEGIC OPPORTUNITIES LLC<br>
                  BY INNOVIVA, INC (IT MANAGING MEMBER)</div>
              </td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">By:</div>
              </td>
              <td style="width: 27.67%; vertical-align: top;">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;"><u>/s/ Pavel Raifeld&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
                  </u></div>
              </td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">Name: Pavel Raifeld</div>
              </td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">
                <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">Title: Chief Executive Officer</div>
              </td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9.9%; vertical-align: top;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 27.67%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
              <td style="width: 26.3%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 23.6pt; margin-left: 23pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 23.6pt; margin-left: 23pt;"> <br>
      </div>
      <br>
      <div><br>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>i40476268b.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: asdf
         Document created using EDGARfilings PROfile 7.2.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 99.1</div>
    <div><br>
    </div>
    <div style="text-align: center;">JOINT FILING AGREEMENT</div>
    <div><br>
    </div>
    <div>In accordance with Rule 13d&#8722;1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each
      of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of Armata Pharmaceuticals, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence
      thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 27<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of January, 2021.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z148780b19448493c93e84a8acff9efdd" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">INNOVIVA, INC.</div>
          </td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">By:</div>
          </td>
          <td style="width: 27.67%; vertical-align: top;">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;"><u>/s/ Pavel Raifeld&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
              </u></div>
          </td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">Name: Pavel Raifeld</div>
          </td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">Title: Chief Executive Officer</div>
          </td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">INNOVIVA STRATEGIC OPPORTUNITIES LLC<br>
              BY INNOVIVA, INC (IT MANAGING MEMBER)</div>
          </td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">By:</div>
          </td>
          <td style="width: 27.67%; vertical-align: top;">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;"><u>/s/ Pavel Raifeld&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
              </u></div>
          </td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">Name: Pavel Raifeld</div>
          </td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">
            <div style="margin-right: 23.6pt; font-family: 'Times New Roman', Times, serif;">Title: Chief Executive Officer</div>
          </td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.9%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 27.67%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.3%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
